Filter Results:
(746)
Show Results For
- All HBS Web (746)
- Faculty Publications (147)
Show Results For
- All HBS Web (746)
- Faculty Publications (147)
- 11 May 2022
- Blog Post
MoMBAs: The Inspiring Student Mothers of HBS
mothers on par with student fathers. Female professors on par with male professors. A female dean. Even more diversity of race, political thought, socioeconomic upbringing, among many other areas View Details
- 22 Aug 2005
- Research & Ideas
The Hard Work of Failure Analysis
that health care organizations typically fail to analyze or make changes even when people are well aware of failures. Whether medical errors or simply problems in the work process, few hospital organizations... View Details
Keywords: by Amy Edmondson & Mark D. Cannon
- 01 Jun 2000
- News
The Business of Biotech
could replace the painful prick of a vaccination needle. And as "delivery vehicles" for medicines proliferate, new distribution channels, such as supermarkets and health clubs, could offer products alongside... View Details
Keywords: Julia Hanna
- 14 Jun 2010
- Research & Ideas
The Hard Work of Measuring Social Impact
requires greater access to education, health care, and employment resources; at the same time, you might be trying to influence public policy on issues that affect the homeless. That involves a whole set of... View Details
Keywords: by Julia Hanna
- 28 Nov 2011
- Research & Ideas
Rethinking the Fairness of Organ Transplants
create a policy. The group's proposed method determines how many life years can be added by looking at the expected survivability for every case. "The new system will explicitly give points based on the likelihood View Details
- 01 Mar 2008
- News
Class of 2007 Fellowship Awarded
development. Kim focused on developing a sustainable model for delivering health care to rural India. “If you create a profitable solution, it can be scalable,” he explains. Upon earning his MBA, Kim is committed to helping people in... View Details
- December 2013
- Article
Measuring the Value of Process Improvement Initiatives in a Preoperative Assessment Center using Time-driven Activity-based Costing
By: Katy E. French, Heidi W. Albright, John C. Frenzel, James R. Incalcaterra, Augustin C. Rubio, Jessica F. Jones and Thomas W. Feeley
Background: The value and impact of process improvement initiatives are difficult to quantify. We describe the use of time-driven activity-based costing(TDABC)in a clinical setting to quantify the value of process improvements in terms of cost, time and personnel... View Details
Keywords: Quality Improvement; Value Agenda; Time-Driven Activity-Based Costing; Accounting; Health; Measurement and Metrics; Value; Health Industry; North and Central America
French, Katy E., Heidi W. Albright, John C. Frenzel, James R. Incalcaterra, Augustin C. Rubio, Jessica F. Jones, and Thomas W. Feeley. "Measuring the Value of Process Improvement Initiatives in a Preoperative Assessment Center using Time-driven Activity-based Costing." Healthcare: The Journal of Delivery Science and Innovation 1, nos. 3-4 (December 2013): 136–142.
- May 2024 (Revised February 2025)
- Case
Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell
By: Jon M. Jachimowicz and Alexis Lefort
Brooke Boyarsky Pratt (HBS ’13) enjoyed considerable success in her early career, quickly climbing the ranks to associate partner at McKinsey, and later becoming an executive vice president at Berkadia, a Berkshire Hathaway portfolio company. Throughout these years,... View Details
Keywords: Passion; Career; Career Planning; Purpose; Personal Development and Career; Mission and Purpose; Identity; Business Startups; Health Care and Treatment; Health Disorders; Growth and Development Strategy; Market Entry and Exit; Health Industry; United States
Jachimowicz, Jon M., and Alexis Lefort. "Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell." Harvard Business School Case 424-040, May 2024. (Revised February 2025.)
- Web
Drivers of Competitiveness - Institute For Strategy And Competitiveness
efficiency and prosperity. Key Concepts Productivity Competitivenss is determined by the productivity with which a location uses its human, capital, and natural endowments to create value. Microeconomic Foundations Productivity ultimately... View Details
- 18 Jan 2016
- Research & Ideas
Hazard Warning: The Unacceptable Cost of Toxic Workers
Minor says. Workers are flagged as self-regarding through a series of nuanced questions to determine how much they value others. “If you’re selfish, you’re more likely to steal and bully,” Minor says. To... View Details
Keywords: by Roberta Holland
- 20 Sep 2013
- Working Paper Summaries
Historical Origins of Environmental Sustainability in the German Chemical Industry, 1950s-1980s
- 07 May 2009
- Working Paper Summaries
Broadening Focus: Spillovers and the Benefits of Specialization in the Hospital Industry
- 26 Mar 2020
- Research & Ideas
7 Leadership Principles for Managing in the Time of Coronavirus
Cash. The most obvious commercial C of the 7 Cs is Cash. Cash is king at a time of crisis, and everything needs to be done to look both short term and long term at the financial View Details
- Web
Faculty & Researchers - Managing the Future of Work
Bertrand, Zoë B. Cullen, Edward L. Glaeser, and Michael Luca. Workplace Knowledge Flows (pdf) , Quarterly Journal of Economics, 2020. With Jason Sandvik, Richard Saouma, and Nathan Seegert. Determinants... View Details
- Article
Individuals' Decision to Co-Donate or Donate Alone: An Archival Study of Married Whole Body Donors in Hawaii
By: Michel Anteby, Filiz Garip, Paul V. Martorana and Scott Lozanoff
Background: Human cadavers are crucial to numerous aspects of health care, including initial and continuing training of medical doctors and advancement of medical research. Concerns have periodically been raised about the limited number of whole body... View Details
Keywords: Decisions; Health Care and Treatment; Personal Characteristics; Philanthropy and Charitable Giving; Health Industry; Hawaii
Anteby, Michel, Filiz Garip, Paul V. Martorana, and Scott Lozanoff. "Individuals' Decision to Co-Donate or Donate Alone: An Archival Study of Married Whole Body Donors in Hawaii." PLoS ONE 7, no. 8 (August 2012). (e42673. doi:10.1371/journal.pone.0042673.)
- 01 Dec 1998
- News
Managing the Business of Life
however, Glover and her husband, Phil Stapleton, had dreamed of starting a business together. "Phil is one of the best thinkers and practitioners in the environmental health... View Details
- 09 Jun 2024
- Blog Post
The EC Formula: MBA Class of 2024 Looks Back
anything at HBS. I came in with a plan and an idea of who I wanted to be post-HBS, but giving myself the time and space to explore, ask questions, and try new things turns out to be the best thing I ever did! View Details
- 20 Dec 2019
- News
The 19 Musts of 2019
deftly weaves in rich storylines from her experience as a psychotherapist—not just to entertain or teach us about others but to beautifully and subtly teach us even more about ourselves.” —Dr. Darria Long Gillespie (MBA 2005), ER doctor, TV host, View Details
- 22 Feb 2022
- Research & Ideas
Lack of Female Scientists Means Fewer Medical Treatments for Women
treatments that primarily benefit women, yet an examination of biomedical patents filed over a 30-year period revealed a significant shortage of inventions targeting women’s View Details
Keywords: by Kristen Senz
- 2007
- Article
Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation
By: Arthur A. Daemmrich
In the wake of Vioxx, Avandia, and other recent prominent cases of drugs found to cause side effects after marketing, the safety of pharmaceuticals has come to the forefront of American public policy. Press attention, congressional investigations, and legislative... View Details
Keywords: Brands and Branding; Policy; Risk Management; Government Legislation; Risk and Uncertainty; Goals and Objectives; Customers; Health Industry; Health Industry; United States
Daemmrich, Arthur A. "Pharmacovigilance and the Missing Denominator: The Changing Context of Pharmaceutical Risk Mitigation." Pharmacy in History 49, no. 2 (2007): 61–75.